PharmiWeb.com - Global Pharma News & Resources
14-Apr-2021

[2021] Calcium Hydroxylapatite (CaHA) Fillers Market Size, Share, Global Trends, Growth, Industry Research Report, Regional Revenue, Competitive Landscape, Top Companies, Merger, Strategy Profiling, Growing CAGR Value

SEATTLE, April 14, 2021, (PHARMIWEB) — Calcium Hydroxylapatite (CAHA) Fillers Market

Calcium hydroxylapatite is a semi-permanent dermal wrinkle filler that is used in a variety of dermatological applications, including the treatment of facial folds and the replacement of missing facial volume. Calcium hydroxylapatite is an atheistic drug that is used to augment facial soft tissue. It has a high safety profile, as well as high elasticity and viscosity, which contributes to the development of long-term collagen. Physical properties of calcium hydroxylapatite include viscosity, elasticity, and cohesivity. A blunt tip micro-cannula is used to administer calcium hydroxylapatite intravenously.

Request for the trending sample of this report: https://www.coherentmarketinsights.com/insight/request-sample/4254

Covid-19 Impact:

After the outbreak of the COVID-19 pandemic, every industry in the world has been negatively impacted. In the case of the global calcium hydroxylapatite (CAHA) fillers market, safety measures enforced to prevent the spread of COVID-19 contamination have resulted in complications in dermatology surgical treatments. Furthermore, patients with dermatological problems have appointments with hospitals for routine checks. Clinics have limited the number of appointments and are now only seeing vulnerable patients as a result of the pandemic

Drivers:

Increasing aesthetic appeal is expected to propel the growth of calcium hydroxylapatite (CaHA) fillers market. For instance, according to a 2018 survey by GlobalData, around three quarters of South Korean men undertake a beauty or grooming treatment at least once a week.

Restraints:

Soft tissue necrosis, permanent scarring, vision impairment, and blindness are all threats associated with intra-arterial injection of calcium hydroxylapatite filler. Furthermore, the cost of calcium hydroxylapatite per syringe ranges from US$ 650 to US$ 800, rendering it unaffordable for people in middle and low-income countries. These factors are expected to hamper growth of calcium hydroxylapatite (CaHA) fillers market.

Market Taxonomy:

On the basis of strength, the global calcium hydroxylapatite (CaHA) fillers market is segmented into:

  • 1 ml
  • 2 ml
  • Others

On the basis of application, the global calcium hydroxylapatite (CaHA) fillers market is segmented into:

  • Wrinkles
  • Chin Lines
  • Acne Scars
  • Others

On the basis of region, the global calcium hydroxylapatite (CaHA) fillers market is segmented into:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa

Quick Buy – Calcium Hydroxylapatite (CaHA) Fillers Market Research Report: https://www.coherentmarketinsights.com/insight/buy-now/4254

Regional Analysis:

North America is expected to witness significant growth in calcium hydroxylapatite (CaHA) fillers market, owing to pharmaceutical companies focusing on research and development in the field of dermal fillers. For instance, in 2016, RegenScientific, a subsidiary of Cytophill Inc., launched CE-marked Renú soft tissue volumizing filler at the International Masters Course on Aging Science (IMCAS) World Congress 2016.

Europe is also expected to witness significant growth in calcium hydroxylapatite (CaHA) fillers market, owing to pharmaceutical companies focusing on research and development in the field of dermal fillers. For instance, in 2016, Merz Pharma GmbH & Co. KGaA received CE mark for Radiesse with integral 0.3% Lidocaine used for natural production of collagen to replenish lost facial volume.

Competitive Landscape

Key players involved in calcium hydroxylapatite (CaHA) fillers market are Regan Scientific Instruments, Inc., Allergan plc, Galderma Laboratories, L.P, Merz Pharma GmbH & Co. KGaA, Cynosure Inc., Prollenium Medical Technologies, Inc., Dr. Korman Laboratories Ltd., Luminera, CG Bio Co., Ltd, Medyglobal, and Teoxane SA.

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 14-Apr-2021